CA2421056A1 - A polypeptide for use as a diagnostic marker for the presence of colon tumours - Google Patents

A polypeptide for use as a diagnostic marker for the presence of colon tumours Download PDF

Info

Publication number
CA2421056A1
CA2421056A1 CA002421056A CA2421056A CA2421056A1 CA 2421056 A1 CA2421056 A1 CA 2421056A1 CA 002421056 A CA002421056 A CA 002421056A CA 2421056 A CA2421056 A CA 2421056A CA 2421056 A1 CA2421056 A1 CA 2421056A1
Authority
CA
Canada
Prior art keywords
seq
acid sequence
pro
amino acid
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002421056A
Other languages
English (en)
French (fr)
Inventor
Kevin P. Baker
Dan L. Eaton
Ellen Filvaroff
Audrey Goddard
J. Christopher Grimaldi
Austin L. Gurney
Victoria Smith
Jean-Philippe Stephan
Colin K. Watanabe
William I. Wood
Zemin Zhang
Sherman Fong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27585542&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2421056(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/US2000/030873 external-priority patent/WO2001040465A2/en
Priority claimed from PCT/US2001/006520 external-priority patent/WO2001068848A2/en
Priority claimed from PCT/US2001/017092 external-priority patent/WO2001092331A2/en
Priority claimed from PCT/US2001/017800 external-priority patent/WO2001093983A1/en
Priority claimed from PCT/US2001/019692 external-priority patent/WO2002000690A2/en
Priority claimed from PCT/US2001/021066 external-priority patent/WO2002008288A2/en
Priority claimed from PCT/US2001/021735 external-priority patent/WO2002008284A2/en
Application filed by Individual filed Critical Individual
Priority to CA002632702A priority Critical patent/CA2632702A1/en
Publication of CA2421056A1 publication Critical patent/CA2421056A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002421056A 2000-09-01 2001-08-29 A polypeptide for use as a diagnostic marker for the presence of colon tumours Abandoned CA2421056A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002632702A CA2632702A1 (en) 2000-09-01 2001-08-29 Secreted and transmembrane polypeptides and nucleic acids encoding the same

Applications Claiming Priority (45)

Application Number Priority Date Filing Date Title
US22989600P 2000-09-01 2000-09-01
US60/229,896 2000-09-01
US23062100P 2000-09-05 2000-09-05
US60/230,621 2000-09-05
US23514700P 2000-09-22 2000-09-22
US60/235,147 2000-09-22
PCT/US2000/030873 WO2001040465A2 (en) 1999-11-30 2000-11-10 Compositions and methods for the treatment of immune related diseases
USPCT/US00/30873 2000-11-10
US26187801P 2001-01-12 2001-01-12
US60/261,878 2001-01-12
US26215001P 2001-01-16 2001-01-16
US26193901P 2001-01-16 2001-01-16
US26191001P 2001-01-16 2001-01-16
US60/261,939 2001-01-16
US60/262,150 2001-01-16
US60/261,910 2001-01-16
US26439501P 2001-01-25 2001-01-25
US60/264,395 2001-01-25
US26642101P 2001-02-02 2001-02-02
US60/266,421 2001-02-02
US26762301P 2001-02-09 2001-02-09
US60/267,623 2001-02-09
PCT/US2001/006520 WO2001068848A2 (en) 2000-03-01 2001-02-28 Secreted and transmembrane polypeptides and nucleic acids encoding the same
USPCT/US01/06520 2001-02-28
US27439901P 2001-03-09 2001-03-09
US60/274,399 2001-03-09
US28098201P 2001-04-03 2001-04-03
US60/280,982 2001-04-03
US28212901P 2001-04-04 2001-04-04
US28219901P 2001-04-04 2001-04-04
US60/282,199 2001-04-04
US60/282,129 2001-04-04
US29058901P 2001-05-09 2001-05-09
US60/290,589 2001-05-09
PCT/US2001/017092 WO2001092331A2 (en) 2000-05-30 2001-05-25 Compositions and methods for the treatment of immune related diseases
USPCT/US01/17092 2001-05-25
PCT/US2001/017800 WO2001093983A1 (en) 2000-06-02 2001-06-01 Secreted and transmembrane polypeptides and nucleic acids encoding the same
USPCT/US01/17800 2001-06-01
PCT/US2001/019692 WO2002000690A2 (en) 2000-06-23 2001-06-20 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
USPCT/US01/19692 2001-06-20
PCT/US2001/021066 WO2002008288A2 (en) 2000-07-20 2001-06-29 Secreted and transmembrane polypeptides and nucleic acids encoding the same
USPCT/US01/21066 2001-06-29
USPCT/US01/21735 2001-07-09
PCT/US2001/021735 WO2002008284A2 (en) 2000-07-20 2001-07-09 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
PCT/US2001/027099 WO2002024888A2 (en) 2000-09-01 2001-08-29 Secreted and transmembrane polypeptides and nucleic acids encoding the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002632702A Division CA2632702A1 (en) 2000-09-01 2001-08-29 Secreted and transmembrane polypeptides and nucleic acids encoding the same

Publications (1)

Publication Number Publication Date
CA2421056A1 true CA2421056A1 (en) 2002-03-28

Family

ID=27585542

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002632702A Abandoned CA2632702A1 (en) 2000-09-01 2001-08-29 Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA002421056A Abandoned CA2421056A1 (en) 2000-09-01 2001-08-29 A polypeptide for use as a diagnostic marker for the presence of colon tumours

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA002632702A Abandoned CA2632702A1 (en) 2000-09-01 2001-08-29 Secreted and transmembrane polypeptides and nucleic acids encoding the same

Country Status (5)

Country Link
EP (1) EP1341814A2 (de)
JP (2) JP4451059B2 (de)
AU (2) AU2002216610A1 (de)
CA (2) CA2632702A1 (de)
WO (1) WO2002024888A2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX343200B (es) 1998-11-27 2016-10-19 Ucb Pharma Sa Composiciones y metodos para aumentar la mineralizacion ósea.
US20040009535A1 (en) 1998-11-27 2004-01-15 Celltech R&D, Inc. Compositions and methods for increasing bone mineralization
CA2490853A1 (en) * 1999-12-01 2001-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1366156A2 (de) * 2000-06-19 2003-12-03 F. Hoffmann-La Roche Ag Polymorphismen des osteolevin gens
US7094570B2 (en) 2003-03-11 2006-08-22 Ludwig Institute For Cancer Research Isolated nucleic acid molecules which encode a soluble IL-TIF/IL-22 receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof
US7268223B2 (en) 2000-09-22 2007-09-11 Wyeth Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof
CA2434652A1 (en) 2001-01-12 2002-08-29 Genetics Institute, Llc. Type 2 cytokine receptor and nucleic acids encoding same
CA2454185A1 (en) * 2001-07-19 2003-01-30 Innate Pharma Ntb-a, a surface molecule involved in natural killer cells activity
US7893218B2 (en) 2003-06-16 2011-02-22 Stowers Institute For Medical Research Antibodies that specifically bind SOST peptides
US7585501B2 (en) 2002-06-14 2009-09-08 Stowers Institute For Medical Research Compositions and methods for treating kidney disease
US20040023356A1 (en) 2002-06-14 2004-02-05 Robb Krumlauf Wise/Sost nucleic acid sequences and amino acid sequences
FR2844713A1 (fr) * 2002-09-25 2004-03-26 Exonhit Therapeutics Sa Nouvelle cible de l'angiogenese et utilisations
AU2003269557A1 (en) * 2002-10-18 2004-05-04 Lg Life Sciences Ltd. Gene families associated with cancers
BRPI0411552A (pt) 2003-06-16 2006-08-01 Celltech R & D Inc anticorpos especìficos a esclerostina e métodos para aumentar a mineralização óssea
US7592429B2 (en) 2005-05-03 2009-09-22 Ucb Sa Sclerostin-binding antibody
US8003108B2 (en) 2005-05-03 2011-08-23 Amgen Inc. Sclerostin epitopes
CL2008002775A1 (es) 2007-09-17 2008-11-07 Amgen Inc Uso de un agente de unión a esclerostina para inhibir la resorción ósea.
US8921058B2 (en) 2009-10-26 2014-12-30 Externautics Spa Prostate tumor markers and methods of use thereof
US10288617B2 (en) 2009-10-26 2019-05-14 Externautics Spa Ovary tumor markers and methods of use thereof
EP2383578A1 (de) * 2010-04-30 2011-11-02 Externautics S.p.A. Tumormarker und Verwendungsverfahren dafür
IL295275A (en) 2010-05-14 2022-10-01 Amgen Inc High concentration antibody formulations
EA201391248A1 (ru) 2011-03-01 2014-05-30 Эмджен Инк. Биспецифические связывающие агенты
JP2014511842A (ja) 2011-03-25 2014-05-19 アムジエン・インコーポレーテツド 抗スクレロスチン抗体結晶およびその製剤
PT2739311T (pt) 2011-08-04 2018-03-26 Amgen Inc Método para tratamento de defeitos de lacunas ósseas
CA2858974A1 (en) 2011-12-28 2013-07-04 Amgen Inc. Method of treating alveolar bone loss through the use of anti-sclerostin antibodies
AU2013285488B2 (en) 2012-07-05 2018-03-22 Ucb Pharma S.A. Treatment for bone diseases
UY35148A (es) 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
CN107880126B (zh) 2012-12-21 2021-03-30 西雅图基因公司 抗ntb-a抗体及相关组合物和方法
MA41142A (fr) 2014-12-12 2017-10-17 Amgen Inc Anticorps anti-sclérostine et utilisation de ceux-ci pour traiter des affections osseuses en tant qu'élements du protocole de traitement
GB201604124D0 (en) 2016-03-10 2016-04-27 Ucb Biopharma Sprl Pharmaceutical formulation
WO2019191534A1 (en) 2018-03-30 2019-10-03 Amgen Inc. C-terminal antibody variants

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby
US5824504A (en) * 1996-09-26 1998-10-20 Elshourbagy; Nabil A. Human 7-transmembrane receptor and DNA
WO1999063088A2 (en) * 1998-06-02 1999-12-09 Genentech, Inc. Membrane-bound proteins and nucleic acids encoding the same
WO1998039448A2 (en) * 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins
EP0998490A2 (de) * 1997-03-25 2000-05-10 Genetics Institute, Inc. Sekretierte proteine und polynukleotide, die für diese kodieren
DE19817557A1 (de) * 1998-04-09 1999-10-21 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Ovartumorgewebe
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
AU3774300A (en) * 1999-06-02 2000-12-18 Genentech Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same

Also Published As

Publication number Publication date
WO2002024888A3 (en) 2003-07-03
CA2632702A1 (en) 2002-03-28
JP4451059B2 (ja) 2010-04-14
WO2002024888A2 (en) 2002-03-28
JP2006223304A (ja) 2006-08-31
AU2002216610A1 (en) 2002-04-02
JP2004526412A (ja) 2004-09-02
AU1661002A (en) 2002-04-02
EP1341814A2 (de) 2003-09-10

Similar Documents

Publication Publication Date Title
US7589172B2 (en) PRO256 polypeptides
US7504480B2 (en) PRO10275 polypeptides
US7297333B2 (en) Anti-PRO10268 antibodies
US7304126B2 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7582293B2 (en) Anti-PRO6308 antibodies
US7297770B2 (en) PRO6496 polypeptides
US7294696B2 (en) PRO7168 polypeptides
EP2228446A1 (de) Sekretierte und transmembrane Polypeptide, sowie dafür codierende Nukleinsäuren
CA2421056A1 (en) A polypeptide for use as a diagnostic marker for the presence of colon tumours
CA2378403A1 (en) Novel polynucleotides and method for the use thereof
CA2361221A1 (en) Novel protein which induces chondrocyte differentiation
US7728108B2 (en) PRO1550 polypeptides
US20020137909A1 (en) Novel cytokine receptors and nucleic acids encoding the same
US7189817B2 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7332578B2 (en) Anti-pro4407 antibodies
US7238790B2 (en) PRO1313 polypeptides
US20060073549A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7452975B2 (en) Anti-PRO7168 antibodies
US7795412B2 (en) Nucleic acids encoding PRO6308 polypeptides and related vectors and host cells
US7297769B2 (en) PRO698 polypeptides
US20060073556A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20060074228A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20060073557A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20060073554A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1944317A2 (de) Sekretierte und Transmembran-Polypeptide sowie Nukleinsäure zu deren Kodierung

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued